For a period of 8 years, a group of researchers supervised people with implants of deep brain simulation. The study suggests that this treatment is capable of benefiting people with acute depression. Further, authorities in the United States have already given green signal for deep brain simulation for a number of diseases. This also includes obsessive-compulsive disorder, epilepsy, Parkinson’s disease, and essential tremor.
The mode of treatment comprises implantation of a stimulator in the chest or abdomen and wires into the brain. Moreover, the stimulator sends out small electrical pulses to the implanted wires through a connection placed beneath the skin.
Simulation in the Subcallosal Cingulate for Effective Treatment Resistant Depression
In this procedure, surgeons place the wires in certain parts of the brain. Additionally, these parts play a vital role in generating symptoms of certain medical conditions. A case in point is Parkinson’s disease in which wires are placed into the area of the brain that regulates movement.
In this new study, the surgeons placed wires in the subcallosal cingulate area. Dr. Helen S. Mayberg, senior author of the research. Of note, her team have been studying subcallosal cingulated area as a probable target for acute depression over a decade. Moreover, Dr. Mayberg is the founding director Nash Family Center for Advanced Circuit Therapeutics.
In a previous study in 2005, it was revealed that deep brain stimulation of subcallosal cingulate area could possibly prove to be advantageous for people suffering from acute depression. Further, these patients did not benefit from other modes of treatment that were available.
28 people took part in the study, out of which 14 participants completed the entire tenure of 8 years of follow-up. Notably, another 11 people completed at least half of the study tenure. At the end, the researchers arrived at the conclusion that deep brain simulation of the subcallosal cingulate area for a long period of time is promising for treating severe depression.
The American Journal of Psychiatry published the study.